- Report
- October 2024
- 191 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- March 2025
- 186 Pages
Global
From €3227EUR$3,545USD£2,741GBP
€3585EUR$3,939USD£3,045GBP
- Report
- July 2024
- 170 Pages
Global
From €5416EUR$5,950USD£4,600GBP
- Report
- April 2025
- 739 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 168 Pages
Global
From €5324EUR$5,850USD£4,522GBP
- Report
- April 2025
- 307 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- March 2025
- 175 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- February 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- July 2024
- 105 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- July 2024
- 100 Pages
Global
From €3413EUR$3,750USD£2,899GBP
- Report
- November 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- May 2024
- 200 Pages
Global
From €3777EUR$4,150USD£3,208GBP
- Report
- May 2023
- 150 Pages
Global
From €5416EUR$5,950USD£4,600GBP
- Report
- October 2022
- 118 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- February 2024
- 119 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- June 2022
- 112 Pages
Global
From €4323EUR$4,750USD£3,672GBP

Gallium-68 is a radioactive isotope used in Nuclear Medicine and Radiopharmacology. It is used in the production of PET (Positron Emission Tomography) radiopharmaceuticals, which are used to diagnose and treat a variety of diseases. Gallium-68 is produced through the irradiation of enriched zinc-68 in a nuclear reactor, and is then used to produce a variety of PET radiopharmaceuticals. These radiopharmaceuticals are used to diagnose and treat cancer, heart disease, neurological disorders, and other diseases.
Gallium-68 is a key component of the Nuclear Medicine and Radiopharmacology market, and is used in the production of a variety of PET radiopharmaceuticals. Companies in the market include GE Healthcare, Bracco Imaging, Mallinckrodt Pharmaceuticals, and Lantheus Medical Imaging. Show Less Read more